About

Eli Lilly and Company is a global leader in pharmaceutical innovation, dedicated to creating medicines that help people live longer, healthier, more active lives. Their focus spans major therapeutic areas including diabetes, oncology, immunology, and neuroscience, with a strong commitment to research and development.

Key facts

At-a-glance profile data

Website: lilly.com
Headquarters: Indianapolis, United States
Portfolio companies: 5
Stages: Series A
Series D
Cheque size: $24M to $290M
Sector focus: Biotechnology
Pharmaceuticals
Healthcare

Recent investments

Recent funding rounds Eli Lilly took part in
Date	Company	Round	Amount
19 Feb 2024	Divergent	Series D	$290M
23 Jan 2024	BreezeBio	Series A1	$24M
23 Sept 2021	BreezeBio	Series A	$26M

Scores

Measured, not editorial

Ahrefs DRMeasured by Ahrefs

86/100Top 25%

Q1 19median 44Q3 71

What this measures

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Check any domain free

API & MCP SecurityMeasured by StartupHub.ai

Measured live, on request

What this measures

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Scan this site yourself

Add first review

Frequently asked

What companies has Eli Lilly invested in?

Eli Lilly has invested in Divergent, BreezeBio, Circle Pharma, InduPro, Inc., Alchemab Therapeutics.